Invention Grant
- Patent Title: Thiazolidin-4-one derivatives
-
Application No.: US13570956Application Date: 2012-08-09
-
Publication No.: US08524752B2Publication Date: 2013-09-03
- Inventor: Christoph Binkert , Martin Bolli , Boris Mathys , Claus Mueller , Michael Scherz , Oliver Nayler
- Applicant: Christoph Binkert , Martin Bolli , Boris Mathys , Claus Mueller , Michael Scherz , Oliver Nayler
- Applicant Address: CH Allschwil
- Assignee: Actelion Pharmaceuticals Ltd.
- Current Assignee: Actelion Pharmaceuticals Ltd.
- Current Assignee Address: CH Allschwil
- Agency: Hoxie & Associates, LLC
- Priority: WOPCT/EP03/13072 20031121
- Main IPC: A01N43/78
- IPC: A01N43/78 ; A61K31/425 ; C07D277/00 ; C07D327/04 ; C07D343/00
Abstract:
The invention relates to pharmaceutical compositions containing at least one thiazolidin-4-one derivative to prevent or treat disorders associated with an activated immune system. Furthermore, the invention relates to novel thiazolidin-4-one derivatives notably for use as pharmaceutically active compounds. Said compounds particularly act also as immunosuppressive agents.
Public/Granted literature
- US20120302612A1 NOVEL THIAZOLIDIN-4-ONE DERIVATIVES Public/Granted day:2012-11-29
Information query
IPC分类:
